Jasper Therapeutics to Present at the LifeSci Partners 2nd Annual Genetic Medicines Symposium
REDWOOD CITY, Calif., June 23, 2022 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (NASDAQ: JSPR), a biotechnology company focused on enabling cures with stem cell therapies, today announced that the Company will participate at the LifeSci Partners 2nd Annual Genetic Medicines Symposium on June 28, 2022.
Ronald Martell, Chief Executive Officer, Jeet Mahal, Chief Operating & Financial Officer, and Wendy Pang M.D, Ph.D., Senior Vice President of Research and Translational Medicine, are scheduled to participate in a fireside chat on Tuesday, June 28th at 4:00 PM ET. A live webcast of the presentation will be available at https://wsw.com/webcast/lifesci5/jspr/2165772 and at the Company’s Investor Events webpage.
About Jasper Therapeutics
John Mullaly (investors)
Jeet Mahal (investors)